INHIBIKASE THERAPEUTICS

Company Information
Address 3350 Riverwood Pkwy
Atlanta, GA, 30339-6451

http://inhibikase.com

Information

DUNS: 828325899

# of Employees: 2


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Advanced PML antiviral

    Amount: $1,000,000.00

    Inhibikase Therapeutics is a clinical stage biopharmaceutical company that has developed a host targeted mechanism of action to treat AIDS related and drug induced progressive multifocal leukoenceph ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Novel DFG out inhibitors of Abl-kinases to treat PML

    Amount: $1,787,776.00

    DESCRIPTION provided by applicant Inhibikase Therapeutics is a clinical stage biopharmaceutical company that has developed a host targeted mechanism of action to treat AIDS related and drug induced pr ...

    SBIRPhase II2016Department of Health and Human Services
  3. System for multidimensional analysis of growth and migration of neurons and neuro

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Inhibikase Therapeutics is a clinical stage, biopharmaceutical company that has developed a host- targeted mechanism of action to treat AIDS-related and drug-induc ...

    SBIRPhase I2013Department of Health and Human Services
  4. PML antiviral for AIDS

    Amount: $265,846.00

    DESCRIPTION (provided by applicant): Inhibikase Therapeutics is an early stage biopharmaceutical company developing a novel strategy for treating infectious disease that occurs in AIDS patients. The ...

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government